✦ LIBER ✦

Single-agent gefitinib with concurrent radiotherapy for locally advanced non-small cell lung cancer harboring mutations of the epidermal growth factor receptor

✍ Scribed by Okamoto, Isamu; Takahashi, Toshiaki; Okamoto, Hiroaki; Nakagawa, Kazuhiko; Watanabe, Koshiro; Nakamatsu, Kiyoshi; Nishimura, Yasumasa; Fukuoka, Masahiro; Yamamoto, Nobuyuki

Book ID: 119320453
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 141 KB
Volume: 72
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2010.08.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-Agent Epidermal Growth Factor Rec

Single-Agent Epidermal Growth Factor Receptor Inhibitor Gefitinib for the Treatment of Patients with Advanced Non—Small-Cell Lung Cancer and Poor Performance Status

✍ Nagla Abdel Karim; Salma Musaad; Abdul Rahman Jazieh 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 92 KB

Efficacy of gefitinib for non-adenocarci

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports

✍ Takehito Shukuya; Toshiaki Takahashi; Rieko Kaira; Akira Ono; Yukiko Nakamura; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Prospective Study of Epidermal Growth Fa

Prospective Study of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Concurrent With Individualized Radiotherapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

✍ Jing Wang; Ting-Yi Xia; Ying-Jie Wang; Hong-Qi Li; Ping Li; Ji-Dong Wang; Dong-S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Activating Mutations in the Epidermal Gr

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

✍ Lynch, Thomas J.; Bell, Daphne W.; Sordella, Raffaella; Gurubhagavatula, Sarada; 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 442 KB

Prospective Phase II Study of Gefitinib

Prospective Phase II Study of Gefitinib for Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor Gene Mutations

✍ Inoue, A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 262 KB

Prospective phase II study of gefitinib

Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations

✍ Sugio, Kenji; Uramoto, Hidetaka; Onitsuka, Takamitsu; Mizukami, Makiko; Ichiki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB